von Hippel-Lindau综合征中的肿瘤:从头到脚的全面最新综述
本文综述von Hippel-Lindau综合征(VHL)的分子细胞遗传学与临床表现,系统回顾视网膜及中枢神经系统血管母细胞瘤、内淋巴囊肿瘤、胰腺神经内分泌肿瘤与囊肿、透明细胞肾细胞癌、嗜铬细胞瘤、副神经节瘤等多种VHL相关肿瘤的多模态影像特征,并讨论VHL管理的最新进展,包括现行监测与筛查推荐。
要点
- VHL患者可多器官发生良恶性肿瘤,影像在诊断与监测中起重要作用
- 熟悉各类VHL相关肿瘤的影像表现有助于早期检出并指导恰当管理
- 文中汇总了VHL监测与筛查的现行推荐,供影像随访参考
核心结论
- VHL是由3号染色体短臂VHL基因胚系突变所致的常染色体显性遗传性肿瘤病,患者可发生累及多器官系统的多种良恶性肿瘤。
- VHL/缺氧诱导因子通路被认为在VHL相关肿瘤的发病机制中起关键作用。
- 影像在VHL患者的诊断与监测中起重要作用,熟悉各相关肿瘤的临床与影像表现对早期检出和指导恰当管理很重要。
研究设计与样本
- 本文为综述(Comprehensive State-of-the-Art Review),讨论VHL的分子细胞遗传学与临床表现,回顾多模态影像特征并讨论管理最新进展,包括现行监测与筛查推荐。
- 原文未报告检索范围、纳入文献数量与样本量。
关键影像表现/征象
- VHL相关肿瘤包括视网膜血管母细胞瘤、中枢神经系统血管母细胞瘤、内淋巴囊肿瘤、胰腺神经内分泌肿瘤、胰腺囊腺瘤、胰腺囊肿、透明细胞肾细胞癌、肾囊肿、嗜铬细胞瘤、副神经节瘤以及附睾和阔韧带囊腺瘤。
- 原文未报告各肿瘤的具体信号、密度或回声特点。
诊断标准与关键数值
- 临床上当特征性病史与表现已出现时可作出VHL诊断,例如存在两个或两个以上中枢神经系统血管母细胞瘤。
- VHL基因杂合胚系突变的基因检测也可用于确认VHL诊断。
- 原文未报告敏感度、特异度、AUC或具体阈值。
临床应用与阅片要点
- 原文强调熟悉各类VHL相关肿瘤的临床与影像表现有助于早期检出并指导恰当管理。
- 原文提及讨论VHL管理的最新进展,包括现行监测与筛查推荐,但摘要未给出具体推荐条款。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Von Hippel-Lindau syndrome (VHL) is an autosomal-dominant hereditary tumor disease that arises owing to germline mutations in the VHL gene, located on the short arm of chromosome 3. Patients with VHL may develop multiple benign and malignant tumors involving various organ systems, including retinal hemangioblastomas (HBs), central nervous system (CNS) HBs, endolymphatic sac tumors, pancreatic neuroendocrine tumors, pancreatic cystadenomas, pancreatic cysts, clear cell renal cell carcinomas, renal cysts, pheochromocytomas, paragangliomas, and epididymal and broad ligament cystadenomas. The VHL/hypoxia-inducible factor pathway is believed to play a key role in the pathogenesis of VHL-related tumors. The diagnosis of VHL can be made clinically when the characteristic clinical history and findings have manifested, such as the presence of two or more CNS HBs. Genetic testing for heterozygous germline VHL mutation may also be used to confirm the diagnosis of VHL. Imaging plays an important role in the diagnosis and surveillance of patients with VHL. Familiarity with the clinical and imaging manifestations of the various VHL-related tumors is important for early detection and guiding appropriate management. The purpose of this article is to discuss the molecular cytogenetics and clinical manifestations of VHL, review the characteristic multimodality imaging features of the various VHL-related tumors affecting multiple organ systems, and discuss the latest advances in management of VHL, including current recommendations for surveillance and screening. ©RSNA, 2018 An earlier incorrect version of this article appeared online. This article was corrected on April 9, 2018.
引用
- Ganeshan D, Menias CO, Pickhardt PJ, et al. Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review. Radiographics. 2018. PMID: 29601266. doi:10.1148/rg.2018170156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。